SARS-CoV-2 Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024 (NCT06683937) | Assistance Publique - Hôpitaux de Paris | 2025-12-01 |
Track SARS-CoV-2 Disease automatically
Every clearance here is in the API, with alerts when new ones post.